Cerevel Therapeutics Hld. Inc. buy BiotechBee
Start price
24.06.23
/
60%
€29.20
Target price
31.05.26
€45.00
Performance (%)
32.19%
End price
21.01.24
€38.60
Summary
This prediction ended on 21.01.24 with a price of €38.60. With a performance of 32.19% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cerevel Therapeutics Hld. Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
According to BiotechBee what are the pros and cons of Cerevel Therapeutics Hld. Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Cerevel Therapeutics Hld. Inc. diskutieren
@sharewise Hallo, wie kann das hier bitte ein Minus Profit sein ? Bitte mal anschauen. Meine Rendite müsste im Plus sein. Danke.